J. Keller

发表

Advancing age and the risk of bleomycin pulmonary toxicity in a largely older cohort of patients with newly diagnosed Hodgkin Lymphoma.

P. Reagan, K. Carson, K. Sanfilippo, 2019, Journal of geriatric oncology.

Disseminated blastomycosis in a patient on pembrolizumab for metastatic melanoma

L. Cornelius, L. Compton, Meghan M. Heberton, 2019, JAAD case reports.

Moving Beyond Autologous Transplantation in Multiple Myeloma: Consolidation, Maintenance, Allogeneic Transplant, and Immune Therapy.

A. Krishnan, R. Vij, P. Hari, 2016, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Complete Response to Erlotinib and Bevacizumab in a Patient With Biphenotypic (Hepatobiliary) Primary Liver Carcinoma.

Kathryn J Fowler, E. Brunt, M. Amin, 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

Statins Are Associated With Reduced Mortality in Multiple Myeloma.

B. Gage, K. Carson, Tzu‐Fei Wang, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Heartland Virus and Hemophagocytic Lymphohistiocytosis in Immunocompromised Patient, Missouri, USA

A. Lambert, C. Eby, J. E. Staples, 2018, Emerging infectious diseases.

Integrin A2 Mediates Selective Metastasis to the Liver

N. Iizuka, M. Oka, C. Iacobuzio-Donahue, 2009 .

Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry.

P. Woolley, P. Schein, L. Chiazze, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of the incidence of pneumonitis in United States veterans with non-small cell lung cancer receiving durvalumab following chemoradiation.

K. Sanfilippo, S. Luo, E. Knoche, 2020 .

Systemic Therapy for Combined Hepatocellular-Cholangiocarcinoma: A Single-Institution Experience.

Kathryn J Fowler, W. Chapman, E. Brunt, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

Severe Cytokine-Release Syndrome after T Cell-Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti-IL-6 Therapy Is Safe and Well Tolerated.

R. Vij, K. Trinkaus, P. Westervelt, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk-adapted strategies for the treatment of Hodgkin lymphoma

K. Carson, J. Keller, 2015, Expert opinion on drug safety.

Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score

B. Gage, K. Carson, N. Kuderer, 2019, American journal of hematology.

Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: Patterns of care and treatment outcomes.

M. Chicoine, G. Dunn, C. Robinson, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Distant intracranial failure in melanoma brain metastases treated with stereotactic radiosurgery in the era of immunotherapy and targeted agents

E. Leuthardt, J. Dowling, C. Tsien, 2017, Advances in radiation oncology.

Moving Beyond Autologous Transplantation in Multiple Myeloma: Consolidation, Maintenance, Allogeneic Transplant, and Immune Therapy.

A. Krishnan, R. Vij, P. Hari, 2016, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemia

Benjamin L. Schooley, M. Dickson, P. Yarnold, 2020, PloS one.

Targeted treatments for multiple myeloma: specific role of carfilzomib

R. Vij, J. Keller, D. Sugumar, 2015, Pharmacogenomics and personalized medicine.

Predictive ability of the khorana score for venous thromboembolism (VTE) in multiple myeloma (MM).

B. Gage, K. Carson, N. Kuderer, 2018 .

Targeted treatments for multiple myeloma: specific role of carfilzomib

R. Vij, J. Keller, D. Sugumar, 2015, Pharmacogenomics and personalized medicine.